Study: NCT00938184

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 12.5 milligrams tablet
Description: Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 12.5 milligrams tablet
Description: Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 12.5 milligrams tablet
Description: Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 12.5 milligrams tablet
Description: Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 12.5 milligrams tablet
Description: Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 12.5 milligrams tablet
Description: Single dose of paroxetine 12.5 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 25 milligrams tablet
Description: Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 25 milligrams tablet
Description: Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 25 milligrams tablet
Description: Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 25 milligrams tablet
Description: Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 25 milligrams tablet
Description: Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 25 milligrams tablet
Description: Single dose of paroxetine 25 milligrams controlled release tablet will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 50 milligrams tablet
Description: Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 50 milligrams tablet
Description: Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 50 milligrams tablet
Description: Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 50 milligrams tablet
Description: Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 50 milligrams tablet
Description: Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Paroxetine 50 milligrams tablet
Description: Single dose of paroxetine 50 milligrams controlled release tablet (as two tablets of 25 milligrams) will be administered orally.